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Background: Patients with the congenital long QT syndrome (LQTS) typically present to the physician after having a cardiac event. However, 
research on risk stratification in LQTS has been limited to predicting risk factors for a first cardiac event. This study examined the changes in the 
predictive value of traditional clinical and genetic factors in risk assessment for recurrent syncope.
Methods: The Prentice-Williams-Peterson model was used to identify and compare predictors of recurrent syncope in 1695 patients drawn from 
the International LQTS Registry.
Results: Age and gender were independent predictors for both first and recurrent syncopal episodes, whereas prolonged QTc duration (>=500 ms) 
was a significant predictor only for the first syncopal episode (Table). Beta-blocker therapy was significantly associated with reduced risk of recurrent 
syncope (Table). Genotype-specific sub-analysis showed that for patients <13 years of age, LQT1 patients were at greater risk for the first and second 
syncopal episodes as compared to LQT2 patients; whereas, for patients >= 13 years of age, LQT2 patients were at higher risk for recurrent syncope. 
Patients who experienced >2 syncopal episodes had >12-fold (p<0.001) increase in the risk for subsequent ACA or SCD.
Conclusion: The traditional genetic and clinical predictors for cardiac events in LQTS change after the occurrence of a first syncopal event. 
Recurrent syncope is a powerful risk factor for subsequent fatal or near-fatal events. 
Variable Predicting 1st syncope Predicting 2nd syncope Predicting 3rd syncope Predicting 4th Syncope
Female>=13
2.16
(1.53-3.06)
2.13
(1.37-3.30)
1.82
(1.12-2.96)
1.69
(1.30-2.20)
Female<13
0.79
(0.66-0.96)
2.00
(1.28, 3.14)
1.71
(1.04, 2.82)
2.22
(1.63, 3.03)
Male<13
1.26
(1.04-1.52)
2.12
(1.37, 3.30)
1.68
(1.01, 2.80)
1.99
(1.48, 2.66)
QTc>=500
2.15
(1.83-2.53)
1.26
(1.05-1.52)
1.05
(0.83-1.33)
1.01
(0.85-1.21)
Beta Blocker use
0.52
(0.41-0.66)
0.27
(0.21-0.35)
0.43
(0.34-0.54)
0.48
(0.40-0.57)
